Today's News |
|
Pfizer, BioNTech’s coronavirus vaccines get FDA’s ‘fast track’ status
Monday, July 13, 2020
Vancouver, BC, July 13, 2020--Two experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received 'fast track' designation from the U.S. drug regulator, the companies said on Monday.The candidates, BNT162b1 and BNT162b2, are the most advanced of at least four vaccines being assessed by the companies in ongoing trials in the United States and Germany.
|
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|